throbber
AR INSIGHTS
`
`AR INSIGHTS
`
`THE ANATOMICAL RECORD 297:1349–1353 (2014)
`
`Technical Review: In Situ Hybridization
`
`ABSTRACT
`In situ hybridization is a technique that is used to detect nucleotide
`sequences in cells, tissue sections, and even whole tissue. This method is
`based on the complementary binding of a nucleotide probe to a specific
`target sequence of DNA or RNA. These probes can be labeled with either
`radio-, fluorescent-, or antigen-labeled bases. Depending on the probe
`used, autoradiography, fluorescence microscopy, or immunohistochemis-
`try, respectively, are used for visualization. In situ hybridization is exten-
`sively used in research, as well as clinical applications, especially for
`diagnostic purposes. This review discusses the basic technique of in situ
`hybridization. The standard in situ hybridization process is reviewed, and
`different types of in situ hybridization, their applications, and advantages
`and disadvantages are discussed. Anat Rec, 297:1349–1353, 2014. VC 2014
`Wiley Periodicals, Inc.
`
`BACKGROUND
`In situ hybridization is a technique that is used for
`localization and detection of specific DNA and RNA
`sequences in cells, preserved tissue sections, or entire
`tissue (whole mount in situ hybridization, Fig. 1) by
`hybridizing the complementary strand of a nucleotide
`probe to a particular sequence. These hybrids can be
`visualized by autoradiography for probes labeled radio-
`actively or by development of a histochemical chromogen
`for probes labeled nonisotopically. The major advantage
`of in situ hybridization is that it enables researchers to
`determine how the distribution of specific nucleic acids
`is related to protein products of the target gene and
`their relation with cellular structures using immunohis-
`tochemistry (Coulton and de Belleroche, 1992). Investi-
`gation of nucleic acids by in situ hybridization was first
`reported in 1969 (Gall and Pardue, 1969). This approach
`is currently an important tool in scientific research and
`in the clinical setting. The spatial information obtained
`from this method has greatly contributed to researchers,
`understanding of many diverse areas of research, such
`as viral
`infection, gene mapping, cytogenetics, gene
`expression, and prenatal diagnosis and development.
`
`BASIC PRINCIPLES OF IN SITU
`HYBRIDIZATION
`The objective of in situ hybridization is to determine
`the presence or absence of DNA or RNA sequences of
`interest, as well as to localize these sequences to specific
`cells or chromosomal sites (Rautenstraub and Liehr,
`2002). Particular sequences are identified within cells
`
`by taking advantage of a property of nucleic acids (i.e.,
`their ability to specifically anneal to each other to form
`hybrids). This process can be used for two complemen-
`tary strands of DNA, and for RNA-to-DNA and RNA-to-
`RNA combinations. Additionally, hybrids between natu-
`ral and artificial nucleic acids are possible. After a
`labeled probe is annealed to matching sequences in fixed
`cells or tissue, the hybridized probe is visualized. When
`one of the two strands is labeled, the annealed hybrids
`can be detected by various methods, including isotopic
`and
`nonisotopic
`(fluorescent
`and
`nonfluorescent)
`approaches. The basic considerations for the process of
`in situ hybridization are discussed below.
`
`Preparation of Tissue
`
`Pretreatment steps can be performed before hybrid-
`ization to increase hybridization efficiency and reduce
`nonspecific background staining (Jin and Llyod, 1997).
`Treatment with proteases (proteinase K is the most com-
`mon) is an important step to facilitate access of the tar-
`get nucleic acid. Acetylation of sections with 0.25%
`acetic anhydride/0.1 M triethanolamine reduces the
`binding of charged probes to tissues. Optimization of tis-
`sue processing, including fixation and storage, is impor-
`tant for detecting intracellular nucleic acids. Fixation
`for in situ hybridization needs to preserve DNA/RNA
`and tissue morphology. In situ hybridization can be per-
`formed on cell samples, such as smears and cytospins,
`and on tissue sections (e.g., frozen and paraffin). Frozen
`tissue is better than paraffin-embedded tissue for pre-
`serving nucleic acids (Egger et al., 1994). Optimally pre-
`served cells should be used for in situ hybridization to
`
`VVC 2014 WILEY PERIODICALS, INC.
`
`10x Genomics EX1023
`
`

`

` 19328494, 2014, 8, Downloaded from https://anatomypubs.onlinelibrary.wiley.com/doi/10.1002/ar.22944, Wiley Online Library on [27/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
`
`1350
`
`ELLEN JENSEN
`
`Problems associated with radioisotope labeling include a
`long exposure time, poor spatial resolution, risk of expo-
`sure to radioactivity, and disposal of radioactive waste.
`For nonisotopic labeling, compounds including biotin,
`fluorescein, digoxigenin, alkaline phosphatase, or bromo-
`deoxyuridine are used and are visualized by histochem-
`istry or immunohistochemistry (Jin and Llyod, 1997).
`Problems associated with nonisotopic labeling are that it
`is generally considered not as sensitive as radioactive
`labeling, and the hybridization results are difficult to
`quantify.
`
`Advantages and Disadvantages of In Situ
`Hybridization
`A major advantage of in situ hybridization is that it
`enables maximum use of tissue that is difficult to
`obtain (e.g., embryos and clinical biopsies). Hundreds of
`different hybridizations can be performed on the same
`tissue. Libraries of tissues can be formed and stored in
`the freezer for future use. A disadvantage of applying
`in situ hybridization techniques is the difficulty in iden-
`tifying targets that have low DNA and RNA copies.
`However, approaches are continually being developed to
`in situ hybridization by
`improve the sensitivity of
`amplifying either target nucleic acid sequences before
`in situ hybridization or by detecting the signal after
`completion of hybridization (Qian and Llyod, 2003).
`These approaches are discussed in the following
`section.
`
`TYPES OF IN SITU HYBRIDIZATION
`Since the first appearance of in situ hybridization,
`many different methods have been developed. Some of
`the more common methods are discussed below.
`
`Increasing Sensitivity Before In Situ
`Hybridization
`PCR with in situ hybridization (in situ PCR) is used
`for amplification of specific DNA or RNA sequences in
`cells or tissue sections. The copy numbers are increased
`by in situ PCR to detectable levels by standard methods
`of in situ hybridization (Long, 1998; Nuovo, 2001). In
`situ PCR has mainly been used to identify DNA sequen-
`ces that are not easy to detect using standard in situ
`hybridization. These sequences include human single-
`copy genes, chromosomal translocations, and rearranged
`cellular genes. In situ PCR is also used for mapping
`genomic sequences that have a low copy number in
`metaphase chromosomes. However, in situ PCR has mul-
`tiple problems, including low efficiency of amplification
`and poor reproducibility.
`Primed in situ labeling is a quick, single-step target
`amplification method. This method incorporates labeled
`nucleotides mediated by Taq DNA polymerase into
`
`image of a 24-hr postfertilization zebrafish embryo
`Fig. 1. A lateral
`in which whole mount in situ hybridization against lyve1 mRNA was
`performed. lyve1 is expressed in the veins and lymphatic vessels. In
`this image,
`the purple staining is present in the main axial veins
`because the lymphatics have not yet begun to develop. Scale
`bar 5 200 mm. The image was kindly provided by Jonathan Astin, the
`University of Auckland. See also Okuda et al. (2012) for details of the
`preparation.
`
`avoid damage to nucleotide sequences. Frozen tissue and
`formalin-fixed tissue that has been stored for several
`years may be used for in situ hybridization.
`
`Probes
`Many different types of probes are used for in situ
`hybridization; these include cDNA, cRNA, and synthetic
`oligonucleotide probes. When choosing a probe for in
`situ hybridization,
`the researcher must
`take into
`account sensitivity and specificity, production facilities,
`how easily the probe penetrates the tissue, stability of
`hybrids,
`the application, and how reproducible the
`method is. The optimal size of the probe is 50–300 bases
`(McNicol and Farquharson, 1997). Probes that can be
`used include double-stranded DNA probes,
`single-
`stranded antisense RNA probes (riboprobes), single-
`stranded DNA probes generated by polymerase chain
`reaction (PCR), synthetic oligodeoxynucleotide probes,
`and oligoriboprobes. The details of these probes, includ-
`ing their advantages and disadvantages, are beyond the
`scope of this article.
`
`Probe Labeling and Signal Detection
`
`There are two main approaches for labeling a probe:
`radioisotope labeling and nonisotope labeling. Radioiso-
`tope labeling is considered as the most sensitive method
`of labeling by many researchers, but others believe that
`nonisotopic methods are just as sensitive. The results of
`radioisotope labeling are easily quantified or semiquanti-
`fied using densitometry counting on film or by
`silver grain counting. Hybridization sites are observed
`by autoradiography with X-ray film or liquid emulsion.
`
`

`

` 19328494, 2014, 8, Downloaded from https://anatomypubs.onlinelibrary.wiley.com/doi/10.1002/ar.22944, Wiley Online Library on [27/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
`
`AR INSIGHTS
`
`1351
`
`newly synthesized DNA, using a single primer elonga-
`tion reaction (Coullin et al., 2002). Primed in situ label-
`ing is easily performed, fast, has a reasonable cost, and
`can be used without cloning technique experience. This
`method has been improved to identify translocations, as
`well as staining of human telomeres and multiple chro-
`mosomes within the same sample. Primed in situ label-
`ing is an alternative option to in situ PCR and
`fluorescence in situ hybridization (FISH), and has many
`potential diagnostic applications. A similar method to
`primed in situ labeling that is used to improve sensitiv-
`ity before in situ hybridization, is called in situ tran-
`scription. This approach is used for visualization of
`mRNA by synthesizing labeled complementary cDNA in
`a cell with a complementary mRNA primer, reverse
`transcription, and labeled nucleotides.
`
`Amplification of the Signal After In Situ
`Hybridization
`
`One of the signal amplification techniques used by
`researchers
`is
`called catalyzed reporter deposition
`(CARD; Kerstens et al., 1995). This method involves dep-
`osition of activated biotinylated tyramine onto electron-
`rich moieties (e.g., tyrosine and phenylalanine) at or
`close to the site of horseradish peroxidase. The CARD
`technique enables an increase in sensitivity of in situ
`hybridization signals by 500-fold to 1000-fold compared
`with conventional avidin–biotin complex approaches.
`The primary advantage of using CARD for in situ
`hybridization is that this technique is performed after
`probe hybridization and washing. Therefore, the specific-
`ity of probe hybridization is not affected. Because of
`CARD’s high sensitivity, there is the potential to amplify
`background signal. However, CARD is easy, quick,
`extremely sensitive, and efficient. In situ hybridization
`including signal amplification by CARD is a good option
`for detecting low copies of nucleic acids and antigens in
`situ.
`Another method for amplifying the signal is branched
`DNA technology. This technique improves detection of
`nucleic acids by increasing the signal rather than ampli-
`fying the target or probe sequence. The branched DNA
`method uses a series of nonisotopic oligonucleotide
`probes, sequentially hybridized, for generating chromo-
`genic and fluorescent
`signals
`(Urdea, 1994). The
`branched DNA method can be used to detect either DNA
`or mRNA, using the same probe set. Advantages of this
`approach are its specificity and increasing the signal,
`but not amplifying the target or probe, meaning that it
`is quantitative.
`
`Fluorescence In Situ Hybridization
`
`FISH is an effective technique that enables direct vis-
`ualization of genetic alterations in the cell. This tech-
`nique has many applications and is generally used to
`
`examine either imbalances, as a gain or loss of segments
`of chromosomal materials, or to show specific break-
`points with or without imbalance (Rautenstraub and
`Liehr, 2002). FISH was initially used for classification of
`chromosomes (Pinkel et al., 1986) but this technique has
`since been adopted in a range of applications in the med-
`ical and biological fields. The driving force of FISH tech-
`nology
`has
`been
`increased
`by
`geneticists
`and
`pathologists interested in human disease because these
`specialists need to characterize genotype-phenotype cor-
`relations. Common uses of FISH in cytogenetic analysis
`are chromosomal gene mapping, characterizing genetic
`abnormalities, identifying genetic abnormalities related
`to genetic disease or neoplasmic disorders, and detecting
`viral genomes
`in interphase nuclei or metaphase
`chromosomes.
`Probes for FISH are labeled by fluorescein, biotin, or
`digoxigenin. Detection of a second signal coupled with
`fluorochromes is then performed (Jin and Lloyd, 1997).
`Probes for FISH can mainly be classified into two cate-
`gories: locus-specific or chromosome paint probes. Locus-
`specific probes are used for detecting a particular gene
`or chromosomal area, and are usually applied for evalu-
`ating deletion or amplification of DNA sequences. Whole
`chromosome paint probes are derived from the complete
`chromosome. These are good for detecting the origin of
`structurally abnormal chromosomes and for identifying
`rearrangements involving different (i.e., nonhomologous)
`chromosomes (Lee et al., 2001). The signals from hybrid-
`ization (fluorescent spots) are visualized by fluorescent
`microscopy. FISH tests are highly sensitive.
`
`Multicolor FISH
`
`An efficient strategy to search for chromosomal abnor-
`malities, even though it is expensive, is the use of multi-
`color FISH techniques (Nath and Johnson, 1999; Lee
`et al., 2001). In multicolor FISH, two or more probes are
`each specifically labeled, combined, and then identified
`with different fluorescent colors (Fig. 2). Using this
`method, scientists can evaluate multiple chromosome
`sites. Types of multicolor FISH include multiplex-FISH,
`spectral karyotyping, cross-species color banding, and
`comparative genomic hybridization. In multiplex-FISH,
`spectral karyotyping of the human genome is performed
`using 24 different colors. Multiplex-FISH enables detec-
`tion of many chromosomal changes in the genome in
`just one hybridization reaction. Additionally, multiplex-
`FISH is a reliable approach for diagnosis. The two sys-
`tems of multiplex-FISH and spectral karyotyping have
`different ways of acquiring and processing images of
`chromosomes, but they both provide the same informa-
`tion. The multiplex-FISH systems and spectral karyotyp-
`ing
`are
`accurate
`for
`detecting
`abnormalities
`of
`chromosomes (Garini et al., 1999). Cross-species color
`banding is a combination of the sensitivity of the tradi-
`tional method of G banding with the objectivity and
`
`

`

` 19328494, 2014, 8, Downloaded from https://anatomypubs.onlinelibrary.wiley.com/doi/10.1002/ar.22944, Wiley Online Library on [27/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
`
`1352
`
`ELLEN JENSEN
`
`not diminish over time, its low cost, the ability to use a
`light microscope, and permanent staining. CISH is an
`appropriate alternative method to FISH, and is broadly
`used by pathologists because it uses bright-field micros-
`copy. A recent study reported a combination approach
`that exploited the advantages of FISH and CISH (Paz
`et al., 2013).
`
`ACKNOWLEDGEMENT
`
`The author thanks Christopher Hall and Jonathan Astin
`for providing the images.
`
`ELLEN JENSEN
`35 Southern Cross Rd.
`Kohimarama, Auckland
`New Zealand
`
`LITERATURE CITED
`
`Coullin P, Roy L, Pellestor F, Candelier JJ, Bed-Hom B, Guillier-
`Gencik Z, Bernheim A. 2002. PRINS, the other in situ DNA labeling
`method useful in cellular biology. Am J Med Genet 107:127–135.
`Coulton GR, de Belleroche J. 1992. In situ hybridization: Medical
`applications. Dordrecht: Springer.
`Egger D, Troxler M, Bienz K. 1994. Light and electron microscopic
`in situ hybridization: non-radioactive labeling and detection, dou-
`ble hybridization, and combined hybridization–immunocytochem-
`istry. J Histochem Cytochem 42:815–822.
`Gall JG, Pardue ML. 1969. Formation and detection of RNA–DNA
`hybrid molecules in cytological preparation. Proc Natl Acad Sci
`USA 63:378–383.
`Garini Y, Gil A, Bar-Am I, Cabid D, Katzir N. 1999. Signal to noise
`analysis of multiple color
`fluorescence imaging microscopy.
`Cytometry 35:214–226.
`Hall CJ, Boyle RH, Astin JW, Flores MV, Oehlers SH, Sanderson
`LE, Ellett F, Lieschke GJ, Crosier KE, Crosier PS. Immunores-
`ponsive gene 1 augments bactericidal activity of macrophage-
`lineage cells by regulating b-oxidation-dependent mitochondrial
`ROS production. 2013. Cell Metab 18:265–278.
`Harrison CJ, Yang F, Cheung K-L, O’Brien PC, Hennessy BJ,
`Prentice HG, Ferguson-Smith M. 2001. Cross-species color band-
`ing in ten cases of myeloid malignancies with complex karyo-
`types. Genes Chromosomes Cancer 30:15–24.
`Jin L, Lloyd, RV. 1997. In situ hybridization: methods and applica-
`tions. J Clin Lab Anal 11:2–9.
`Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW,
`Waldman F, Pinkel D. 1992. Comparative genomic hybridization
`for molecular cytogenetic analysis of solid tumors. Science 258:
`818–821.
`Kerstens HM, Poddighe PJ, Hanselaar AG. 1995. A novel in situ
`hybridization signal amplification method based on the deposition
`of biotinylated tyramine. J Histochem Cytochem 43:347–352.
`Lee C, Lemyre L, Miron PM, Morton CC. 2001. Multicolor fluores-
`cence in situ hybridization in clinical cytogenetic diagnostics.
`Curr Opin Pediatr 13:550–555.
`Long AA. 1998. In-situ polymerase chain reaction: foundation of the
`technology and today’s options. Eur J Histochem 42:101–109.
`McNicol AM, Farquharson MA. 1997. In situ hybridization and its
`diagnostic applications in pathology. J Pathol 182:250–261.
`
`Fig. 2. A dual fluorescent whole mount in situ hybridization image.
`The image is a confocal z-section within the head of a 3-day postferti-
`lization zebrafish larvae. Expression of
`immunoresponsive gene 1
`(irg1), a marker of activated immune cells (red fluorescence), and apo-
`lipoprotein Eb (apoeb), a marker of microglia (green fluorescence), can
`be seen 1 day after injection of Salmonella into the head. Overlapping
`expression (yellow) shows that these microglia in the head (which are
`the resident immune cells of the brain) have become activated. The
`image was kindly provided by Christopher Hall, the University of Auck-
`land. See also Hall et al. (2013) for details of the preparation.
`
`efficiency of a molecular method (chromosome painting;
`M€uller et al., 1998). This approach uses a chromosome
`painting probe set originating from a species of ape, the gib-
`bon, to examine human chromosomes. Cross-species color
`banding is inferior to that of multiplex-FISH/spectral kar-
`yotyping for identifying translocations between different
`chromosomes, but it can be useful for identifying certain
`intrachromosomal rearrangements (Harrison et al., 2001).
`Comparative genomic hybridization is a good method for
`investigating the genetic composition of cells from two dif-
`ferent sources. This approach is used for investigating var-
`iations in DNA copy number (e.g., gains and losses).
`Comparative genomic hybridization can reveal genetic
`alterations in all areas of the genome in one experiment by
`FISH and image analysis by computer (Kallioniemi et al.,
`1992). However, comparative genomic hybridization is tech-
`nically difficult and resolution is limited.
`
`Chromogenic In Situ Hybridization (CISH)
`
`CISH enables examination of gene amplification, gene
`deletion, chromosomal translocations, and chromosomal
`number. This approach uses conventional peroxidase or
`alkaline phosphatase reactions using bright-field micros-
`copy on tissues fixed by formalin and embedded in paraf-
`fin (Tanner et al., 2000). These peroxidase- or alkaline
`phosphatase-labeled reporter antibodies interact with a
`hybridized DNA probe, and are then observed with an
`enzymatic
`reaction. Tissue morphology and genetic
`abnormalities can be viewed at the same time with
`CISH. Advantages of CISH are the fact that signals do
`
`

`

` 19328494, 2014, 8, Downloaded from https://anatomypubs.onlinelibrary.wiley.com/doi/10.1002/ar.22944, Wiley Online Library on [27/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
`
`AR INSIGHTS
`
`1353
`
`M€uller S, O’Brien PC, Ferguson-Smith MA, Wienberg J. 1998.
`Cross-species color segmenting: a novel tool in human karyotype
`analysis. Cytometry 33:445–452.
`Nath J, Johnson KL. 1999. A review of fluorescence in situ hybrid-
`ization (FISH): Current status and future prospects. Biotech His-
`tochem 75:54–78.
`Nuovo GJ. 2001. Co-labeling using in situ PCR: a review. J Histo-
`chem Cytochem 49:1329–1339.
`Okuda KS, Astin JW, Misa JP, Flores MV, Crosier KE, Crosier PS.
`2012. lyve1 expression reveals novel lymphatic vessels and new
`mechanisms for lymphatic vessel development in zebrafish. Devel-
`opment 139:2381–2391.
`Paz N, Zabala A, Royo F, Garcıa-Orad A, Zugaza JL, Parada LA.
`2013. Combined fluorescent-chromogenic in situ hybridization for
`identification and laser microdissection of
`interphase chromo-
`somes. PLoS One 8:e60238.
`Pinkel D, Straume T, Gray JW. 1986. Cytogenetic analysis using
`quantitative, high sensitivity,
`fluorescence hybridization. Proc
`Natl Acad Sci USA 83:2934–2938.
`Qian X, Lloyd RV. 2003. Recent developments in signal amplifica-
`tion methods for in situ hybridization. Diagn Mol Pathol 12: 1–13.
`
`Rautenstraub BW, Liehr T. 2002. FISH Technology. Berlin:
`Springer-Verlag.
`Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart
`MJ, Isola J. 2000. Chromogenic in situ hybridization: a practical
`alternative for fluorescence in situ hybridization to detect HER-2/
`neu oncogene amplification in archival breast cancer samples. Am
`J Pathol 157:1467–1472.
`Urdea MS. 1994. Branched DNA signal amplification. Biotechnology
`12:926–928.
`
`*Correspondence to: Ellen Jensen, 35 Southern Cross Rd.
`Kohimarama, Auckland, New Zealand, 1701.
`E-mail: ellen_knapp2004@yahoo.com.au
`or ellenknapp1@gmail.com
`Received 3 January 2014; Accepted 2 April 2014.
`DOI 10.1002/ar.22944
`Published online 9 May 2014 in Wiley Online Library
`(wileyonlinelibrary.com).
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket